Tejnaksh Healthcare Share Price Today | Stock Price & Tejnaksh Healthcare Share Screener
As of October 5, 2026, the live Tejnaksh Healthcare share price (BSE: TEJNAKSH) is ₹12.21, down 2.63% from the previous close, with shares trading between ₹11.66 and ₹12.98 in today's trading session, and a 52-week range of ₹11.18–₹17.78. Check Tejnaksh Healthcare yearly highs lows for the annual price range and momentum. Use the Tejnaksh Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Tejnaksh Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Tejnaksh Healthcare Share Price Chart
Track the current stock price of Tejnaksh Healthcare with an interactive chart. Analyse TEJNAKSH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Tejnaksh Healthcare stock quote in one place.
The quote of ₹12.21 sits between the 52-week low of ₹11.18 and the 52-week high of ₹17.78, and the latest session moved -2.63% from the previous close.
Tejnaksh Healthcare Company Profile - Fundamental Screener
Screen Tejnaksh Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TEJNAKSH shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE030T01027.
Company Details
Classification
Identifiers and Leadership
Tejnaksh Healthcare Balance Sheet Screener
Screen TEJNAKSH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹30, down from ₹30 in 2025.
Latest statistics put total assets at ₹30 and shareholder funds at ₹28, with a leverage ratio of 0.02.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 30 | 30 | 31 | 31 | 30 | 25 | 25 | 22 | 20 | 16 |
| Current Assets | 5 | 6 | 6 | 6 | 5 | 3 | 7 | 5 | 3 | 2 |
| Fixed Assets | 20 | 21 | 23 | 23 | 15 | 15 | 17 | 17 | 15 | 14 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 6 | 7 | 7 | 5 | 8 | 6 | 6 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 28 | 27 | 24 | 22 | 21 | 18 | 16 | 14 | 10 | 8 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 2 | 2 |
| Reserves & Surplus | 17 | 16 | 13 | 12 | 10 | 7 | 5 | 3 | 8 | 6 |
Tejnaksh Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Tejnaksh Healthcare income statement and profit fundamentals. Analyze TEJNAKSH quarterly results. Tejnaksh Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹3 and net profit was ₹0, equal to earnings per unit of ₹0.13, at an operating margin of 26%.
In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹3 and net profit of ₹0.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Expenses | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 26.00% | 28.00% | 26.00% | 26.00% | 23.00% | 22.00% | 36.00% | 34.00% | 34.00% | 31.00% | 34.00% | 37.00% | 17.00% | 14.00% | 27.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| EPS | 0.13 | 0.17 | 0.14 | 0.15 | 0.12 | 0.21 | 0.38 | 0.31 | 0.29 | 0.25 | 0.27 | 0.28 | 0.08 | -0.01 | 0.31 |
Tejnaksh Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen TEJNAKSH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹2.
Over the same period, investing activities provided ₹0 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 2 | 0 | 4 | 2 | 9 | 1 | 1 | 3 | 5 | 2 |
| Investing Activities | 0 | 4 | -1 | -1 | -11 | 2 | -1 | -2 | -3 | -8 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | -4 | -2 | -1 | 2 | -3 | 0 | -2 | -1 | 6 |
| Net Cash Flow | 0 | 0 | 1 | -1 | 0 | 0 | 0 | -1 | 1 | 1 |
Tejnaksh Healthcare Shareholding Pattern Screener
See Tejnaksh Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Tejnaksh Healthcare promoter holding and ownership changes for TEJNAKSH on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 73.83%, foreign institutions 0.00%, domestic institutions 0.00% and the public 23.49%, spread across 4,395 shareholders.
The shareholder count was 4,395 in 2026-Jun, compared with 4,414 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.49% | 23.58% | 23.72% | 23.73% | 23.60% | 23.58% | 23.65% | 23.84% |
| Other Holding | 2.67% | 2.59% | 2.44% | 2.44% | 2.57% | 2.58% | 2.52% | 2.33% |
| Shareholder Count | 4,395 | 4,414 | 4,452 | 4,550 | 4,552 | 4,493 | 4,496 | 4,067 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Tejnaksh Healthcare. Tejnaksh Healthcare dividend yield can be compared with peers and other stocks in the market.
Tejnaksh Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Tejnaksh Healthcare stock. Check TEJNAKSH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Tejnaksh Healthcare Market Events Screener - Corporate Actions
Get Tejnaksh Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Tejnaksh Healthcare stock events that may affect TEJNAKSH share price, along with derivatives, futures and options activity and sector gainers.
14 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -5.38% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 11.65% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 9.73% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 6.30% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -1.66% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -1.62% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.77% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.72% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -2.79% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -0.42% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.42% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -1.20% |
| 2023-07-19 | 2023-07-19 | Split | 5:10 | -1.33% |
| 2018-04-26 | 2018-04-28 | Bonus | 36:10 | 25.55% |
Tejnaksh Healthcare Competitors Screener - Peer Stocks Comparison
Screen TEJNAKSH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 33,035 | 59.65 | 2,864 | 12.11% | 510 | 56.98 |
| Vijaya Diagnostic Centre | 15,459 | 82.40 | 835 | 19.34% | 173 | 51.12 |
| Metropolis Healthcare | 11,770 | 58.51 | 1,671 | 24.15% | 191 | 45.27 |
| Thyrocare Technologies | 8,744 | 49.67 | 846 | 20.48% | 163 | 40.92 |
| Nephrocare Health Services | 6,724 | 79.69 | 1,023 | 32.93% | 77 | 37.77 |
| Suraksha Diagnostic | 1,819 | 51.63 | 314 | 22.55% | 31 | 61.81 |
| Krsnaa Diagnostics | 1,742 | 17.83 | 816 | 9.90% | 101 | 41.10 |
| 3B BlackBio DX | 1,372 | 24.11 | 142 | 27.17% | 61 | 66.56 |
| One Global Service Provider | 1,046 | 14.38 | 499 | 237.48% | 70 | 49.71 |
| Health X Platform | 891 | -34.21 | 1,319 | 12.68% | -3 | 38.00 |
Tejnaksh Healthcare Company Announcements - News & Reports Screener
Screen TEJNAKSH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated September 4, 2026 and September 4, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Closure of Trading Window | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of 19Th Annual General Meeting Of The Company To Be Held On 29Th September 2026 | - |
| 2026-08-13 | Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30 June 2026. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of- Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-08 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window | - |
| 2026-07-19 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-30 | Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026. | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30. | - |
| 2026-05-20 | Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-09 | Reply To The Clarification Sought By The Stock Exchange With Reference To The Significant Movement In Share Price Of The Securities Of The Company; | - |
| 2026-04-08 | Clarification sought from Tejnaksh Healthcare Ltd | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-07 | Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025. | - |
| 2026-02-07 | Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On 7Th Feb 2026 | - |
| 2026-02-02 | Board Meeting Intimation for 1. To Consider And Approve Un-Audited Financial Results (Standalone & Consolidated) For The Quarter 31St December 2025. 2. Any Other Matter With The Permission Of The Chair. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹12.21, within a 52-week range of ₹11.18 to ₹17.78. The P/E ratio is 21.62 and the P/B ratio is 0.99, with earnings per unit of ₹0.61. Market capitalisation stands at ₹26.21 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.